Antiulcer Activity of Azima Tetracantha:  A Biochemical Study

 

P Muthusamy1, A Jerad Suresh1 and G Balamurugan2*

1Department of Pharmacognosy, College of Pharmacy, Madras Medical College, Chennai – 03,

2Department of Pharmacology and Toxicology, C. L. Baid Metha College of Pharmacy,  Old Mahabalipuram Road, Jyothi Nagar, Thoraipakkam, Chennai-97. Tamil Nadu, India

*Corresponding Author E-mail:  balamurugangunasekaran@gmail.com

 

ABSTRACT:

The ethanolic extract of Azima tetracantha leaves were investigated for its ulcer protective activity on aspirin and pylorus ligation and cold restraint stress induced ulcer models. Various biochemical parameters such as gastric volume, pH of gastric content,  free acidity and total acidity, dissolved muco substances such as total protein, hexoses, hexosamine, fucose and sialic acid were estimated in 90 % alcoholic precipitate of gastric juice  and histopathological sections were examined on the test and control group animals. The extract at a concentration of 200 and 400 mg/kg exhibited a protective effect on ulcer-induced models in a dose dependent manner and was comparable with the standard drugs ranitidine and omeprazole. Some of the antioxidant enzyme levels (lipid peroxidation, superoxide dismutase and catalase) were also determined. The present study revealed that the extract of A. tetracantha had ulcer protective activity comparable with standard drugs ranitidine and omeprazole, which may be mediated by its antioxidant effects.

 

KEY WORDS:  Azima tetracantha, Antiulcer, Muco proteins, Aspirin plus pylorus ligation, Cold restraint stress, Antioxidant enzymes.

 


INTRODUCTION:

Gastric ulcers arise due to various factors 1. Even though the etiology of gastric ulcers is still debated, it is accepted that ulcers are caused due to net imbalances in mucosal offensive and defensive factors 2. Ulcer therapy is now mainly focused on limiting the deleterious effects of offensive acid secretion, but search for new safer alternative drugs have rekindled the interest in cytoprotective drugs, which protect the gastric mucosa from damaging agents without influencing acid secretion or neutralizing intragastric acidity 3. Although few drugs like sucralfate and prostaglandin analogs, i.e. misoprostol are recognized as cytoprotective agents 4, many natural drugs have been reported to possess this activity 5 - 7. Change in gastric emptying has been reported to be responsible for genesis of ulcers 8. Free radical shave been reported to be responsible for many ailments including gastro duodenal ulcers 9Azima tetracantha Lam (family Salvadoraceae) is a well-known medicinal plant whose root has been advocated for various ailments such as dropsy and rheumatism.

 

Azima tetracantha leaves possess stimulant, expectorant and antispasmodic activities 10; analgesic effect 11 and anti-inflammatory effect 12.  The present study incorporates the evaluation of ulcer protective effects of ethanolic extract of dried leaves of Azima tetracantha by estimating various biochemical parameters of ulcer-induced models.

 

MATERIALS AND METHODS:

Plant collection and Extraction:

The leaves of Azima tetracantha was collected from Chennai district, Tamil Nadu, India in the month of July 2008. Dr. P. Jayaraman, (Director) Plant Anatomy Research Centre, Chennai, confirmed the identity. A voucher specimen was deposited in the Department of Pharmacognosy at Madras Medical College, Chennai. 500 grams of dried leaves of Azima tetracantha was powdered and then soaked in 1500 mL of ethanol overnight. After filtration, the residue obtained was again resuspended in equal volume of ethanol for 48 h and filtered again. The above two filtrates were mixed and the solvent was evaporated in a rotovac evaporator at 40°- 50°C under reduced pressure. A 16% semisolid dark material obtained was stored at 0-4°C until used. A known volume of the residual extract was suspended in 0.5 % Carboxy methylcellulose (CMC) for animal administration.


Table1: Effect of EEAT on pH, gastric volume, free acidity and total acidity

Treatment Groups

pH

Gastric volume (mL/100g)

free acidity (m Eq/L/100g)

Total acidity

(m q/L/100g)

Control

4.13±0.147

1.55±0.1335

58.17±0.2591

44.62±0.4003

APL **

1.333±0.08a**

5.6±0.1065 a ***

66.95±0.5396 a **

78.53±0.2028a

EEAT (200 mg/kg)

3.45±0.11b**

4.383±0.3311 b**

54.13±0.6766 b**

56.2±0.1506b**

EEAT (400 mg/kg)

3.8±0.97 b**

3.283±0.1493 b**

44.07±0.3853 b**

51.98±0.400 b**

Ranitidine (50 mg/kg)

4.2±0.147 b**

2.783±0.1537 b**

40.8±0.2206 b**

7.08±0.2469b**

Data are mean ± SEM., n=6, Statistical significance * p<0.05, **p<0.01, ***p<0.001, a - Group I vs. Group II; b - Group II vs. Groups III, IV and V

 

Table 2: Effect of EEAT on gastric juice mucoprotein (µg/mL) in ALP rats

Treatment Groups

Protein

Total hexoses

Hexosamine

Fucose

Sialic acid

Control

245.3±3.084

458± 6.172

225.3±6.381

104.7±1.8

79.33±1.282

APL

438.3±49.32 a ***

212.5±6.25 a ***

119.8±4.377 a ***

6.9±1.065 a ***

23.0±1.653 a***      

EEAT (200 mg/kg)

369.8±7.507 b**

358.8±9.13 b**

176.3±6.561 b**

88.5±0.7638 b***

52.5±1.522 b**

EEAT (400 mg/kg)

345.5±11.03 b**

07.2±6.61 b**

186.2±5.406 b**

93.17±1.167 b***

61.17±0.945 b**

Ranitidine (50 mg/kg)

305±5.562 b**

438.2±6.8 b**

190.8±5.076 b**

126.2±1.701 b***

69.67±0.843 b**

Data are mean ± SEM., n=6, Statistical significance * p<0.05, **p<0.01, ***p<0.001, a - Group I vs. Group II; b - Group II vs. Groups III, IV and V

 


Experimental Animals:

In bred Wistar rats of either sex obtained from Madras Medical College (Chennai, India) weighing 200-250g were used for the study. They were kept in the departmental animal house at 26 ± 2°C and relative humidity 45-55%, light and dark cycles of 12 and 12 h, respectively for 1 week before and during the experiments. Animals were provided with standard rodent pellet diet (Hindustan Lever) and water ad libitum. The experimental protocol was approved by the Institutional Animal Ethical Committee (IAEC) constituted under CPCESA (Ref No: 10/243 - IAEC 2008)

 

Table 3: Effect of EEAT on Ulcer scores

Treatment Groups

Aspirin and

Pylorus ligation

Cold Restraint Stress

Control

0.10±0.035

0±0        

Ulcer induceda***

2.38±0.0640a***

25.50±0.5627

EEAT (200 mg/kg)

2.25±0.2230b*

22.83±0.3073 b*

EEAT (400 mg/kg)

1.4±0.210 b**

21.33±0.2108 b*

Ranitidine (50 mg /kg)

1.03±0.049 b***

-----

Omeprazole (10 mg/kg)b**

------

16.67±0.0201

Data are mean ± SEM., n=6, Statistical significance * p<0.05, **p<0.01, ***p<0.001, a - Group I vs. Group II; b - Group II vs. Groups III, IV and V

 

Acute toxicity studies:

Albino mice weighing 20-25 g selected by random sampling technique were used in the study. Acute oral toxicity was performed 13. The animals were fasted overnight, provided only water after which extract was administered to the groups orally at the dose level of 5 mg / kg body weight by gastric intubation and the groups were observed for 14 days. If mortality was observed in 2 or 3 animals (out of 6), then the dose administered was assigned as a toxic dose. If mortality was observed in one animal, then the same dose was repeated again to confirm the toxic dose. If mortality was not observed, the procedure was repeated for further higher doses such as 50, 300 and 2000 mg / kg body weight. The animals were observed for toxic symptoms such as behavioral changes, locomotion, convulsions and mortality for 72 h.

 

Aspirin plus pylorus ligation method (APL):

The animals were placed in cages with grating floor to avoid coprophagy and divided into five groups viz, Group I receiving 0.5 % Carboxy methyl cellulose (CMC) served as vehicle control, group II received Aspirin 200 mg / kg p.o suspended in 0.5 % CMC. Groups III and IV received the ethanolic extract of Azima tetracantha (EEAT) at doses of 200 mg / kg and 400 mg/ kg respectively by oral route. Group V received Ranitidine 50 mg / kg orally serving as standard drug control for Aspirin plus pylorus ligation (APL) models. All the extracts and reference drug were suspended in 0.5 % CMC for animal administration. Aspirin was administered once daily for 5 days. Ranitidine and the extracts were administered 30 min before each aspirin administration. On day 6 after last dose, the rats were kept for 18 h fasting. Pylorus ligation was done following the method as described 14. The animals were deprived of water during the postoperative period. After 4 h, stomachs were dissected out and contents were collected in tubes for estimation of biochemical parameters. Ulcers were scored as described 15.

 

Cold restraint stress induced ulcers (CRS):

The animals were placed in cages with grating floor to avoid coprophagy and divided into five groups viz, Group I receiving 0.5 % Carboxy methylcellulose (CMC) served as vehicle control, and group II received Cold Restraint Stress (CRS). Groups III and IV received the extract of  Azima tetracantha (EEAT) at doses of 200 mg / kg and 400 mg/ kg respectively by oral route. Group V received Omeprazole 10 mg/kg and served as drug control. On the day 6, for 18 h fasted rats, CRS was given by strapping the rats on a wooden plank and keeping them immobile for 2 h at 4-6 °C. The animals were then sacrificed by cervical dislocation. The stomach was taken out and cut open along the greater curvature, ulcers were scored 16, and the tissues were subjected to estimate biochemical parameters.

 

Biochemical Estimation:

In APL induced ulcer models the following were estimated by procedures described, gastric volume 16, pH of gastric content 18 free acidity and total acidity 19, Dissolved muco substances such as total protein 20, hesoses, hexosamine, fucose, sialic acid 21 were estimated in 90 % alcoholic precipitate of gastric juice and expressed as µg/ml. In CRS induced ulcer model Lipid peroxidases, LPO 22 expressed as nmol/mg protein, Superoxide dismutase, SOD 23 expressed as activity/mg and Catalase, CAT 24 expressed as units (U) of CAT activity/mg protein were estimated.

 

Statistical Analysis:

The data are expressed as mean ± SEM. Statistical comparisons were performed by one-way ANOVA followed by Dunnet’s‘t’ test. The results were considered statistically significant if the p-values were less than 0.05.

 

RESULTS:

EEAT did not produce any toxic symptoms or mortality up to the dose level of 2000 mg/kg body weight and hence the drug was considered safe for pharmacological screening. According to OECD-423 guidelines for acute oral toxicity, the LD50 dose of 2000 mg/kg and above is categorized as unclassified.

 

Estimation of acid secretory parameters such as pH, gastric volume, free acidity and total acidity was increased significantly in the aspirin administered group. Administration of EEAT exhibited a significant (p < 0.01) reduction in all the parameters and the results were comparable with the standard drug Ranitidine 50 mg/kg (Table 1). Determination of the concentrations of various muco proteins such as total protein, total hexoses, hexosamine, fucose and sialic acid revealed a decrease in ulcer induced group. The extract at 400 mg/kg increased the level of the muco proteins significantly and comparably with the standard drug (p <0. 01) (Table 2). The ulcer scores obtained in ulcer induced group of APL and CRS exhibited an increased score. Administration of the extract exhibited a moderate decrease in the ulcer scores in a dose dependent manner in CRS models and a significant decrease in APL models (p < 0.05 and p < 0.01). The standard drug Omeprazole 10 mg/kg decreased the ulcer score significantly in CRS model (P < 0.01) (Table 3). Effect of EEAT on the levels of SOD, LPO and CAT were satisfactory. The stress-induced group had increased level of SOD, LPO and a decreased level of CAT than control group, which was restored by the administration of EEAT in a dose dependent manner. The results were significant and comparable with the standard drug Omeprazole 10 mg/kg   (p < 0.01) (Table 4).

 

The histopathological sections of the drug treated group in ALP and CRS had shown a reduction in ulcer focus and a hyperplastic gastric mucosa with regenerating mucosal epithelium (Fig 1 and 2).

 

DISCUSSION:

EEAT showed significant dose-dependent ulcer protective effect against cold restraint stress and aspirin plus pylorus ligation induced gastric ulcers. The anomality in ulcer protective effect may be due to variability of factors affecting ulcerogenesis in different models. Ulcers are caused due to imbalances between offensive and defensive mucosal factors 2 and hence the effects of EEAT can be explained based on these factors. Mucin is a viscous glycoprotein with physiochemical properties producing relatively resistant acid barrier 25. It makes up the major part of the mucus, an important pre-epithelial factor that acts as a first line of defence against ulcerogens 26. Increase in mucin can be due to increased levels of individual mucopolysaccharide like sialic acid and total hexoses. The increase in mucosal defence may also be due to decrease in cell exfoliation 27. Hence, the protection afforded by EEAT in APL induced ulcers may be predominantly due to strengthening mucosal defense 2. The ability of EEAT to protect stomach against ulcerogens by neutralizing intra gastric acidity can as well lead it to classify as a cytoprotective agent 3 Prostaglandins have often been quoted as a model cytoprotective agent, although this has been disputed 4. Aspirin, an irreversible COX inhibitor decreases prostaglandin synthesis and reported to produce ulcers both by local and systemic effects. Aspirin has direct irritant effect by increasing the H+ ion transport. On the mucosal epithelial factors, it decreases mucin, surface-active phospholipids bicarbonate secretion mucosal proliferation and on the microvasculature produced damage by formation of free radicals 28. To ascertain this effect, the activity of EEAT was studied on aspirin plus pylorus ligation model, where aspirin is known to further aggravate mucosal damage caused by pylorus ligation 26. It was found that EEAT was effective in this model, suggesting that the activity of EEAT may also involve other defensive factors apart from PG synthesis.

 

The role of the free radicals in gastric ulcerations is well-documented 29. EEAT significantly reduced lipid peroxidation in rat gastric mucosa. Azima tetracantha has been reported to possess antioxidant activity 30 SOD scavenges the super oxide radical O2- , one of the reactive oxygen species (ROS) responsible for lipid


Table 4: Effect of EEAT on LPO, SOD and CAT activities in rat gastric mucosal scrapings

Treatment Groups

LPO (MDA, nmol/g wet tissue)

SOD (Units/g wet tissue)

CAT (Units/g wet tissue)

Control

132.2±1.641

84.17±1.797

51.5±2.363

Restraint stress

265.5±1.544a***

217.2±1.249 a***

15.83±1.078 a***

EEAT (200 mg/kg)

90.5±1.607 b**

155.2±1.989 b**

29.17±2.088 b**

EEAT (400 mg/kg)

52.5±1.945 b***

105.2±2.574 b**

39.67±1.994 b**

Omeprazole (10 mg/kg)

67.0±1.461 b***

93.67±1.202 b**

44.0±2.1600 b**

Data are mean ± SEM., n=6, Statistical significance * p<0.05, ** p<0.01, *** p<0.001, a - Group I vs. Group II; b - Group II vs. Groups III, IV and V

 


peroxidation 31. This reaction leads to increase in generation of producing more oxidative damage 32. CAT and other peroxidases further reduce H2O2- . Hence, the anti oxidant activity in gastric mucosal homogenates observed from the decrease in the LPO may be due to increase in SOD and CAT levels. Stress induced ulceration involves damage by ROS apart from acid and pepsin related factors 33 during stress LPO and SOD were significantly increased and CAT level was significantly decreased. The increase in SOD was due to increased ROS generation during mucosal damage. This led to increased generation of H2O2- and its accumulation due to decreased CAT level. Inactivation of gastric peroximes during stress 34 may also aggravate the mucosal damage. This evidently caused increased lipid peroxidation and mucosal damage as seen from the increase in ulcer scores in comparison to the control group. EEAT effectively alleviated stress induced ulcers with marked decrease in LPO suggesting decrease in oxidative damage. This may be due to restoration of balance between free radical scavenging enzymes SOD and CAT in the gastric mucosa, effectively counteracting the free radicals generated by cascade of reactions as described earlier. Thus the ulcer protective activity of EEAT may also be due to its anti oxidant effect.

 

Hence, the gastro duodenal ulcer protecting effect of EEAT may be due to its predominant effect on the mucosal defensive factors rather than offensive factors. Further conclusion on the precise mechanism of the action can be arrived after studies on its CNS effect and on the mucosal defensive factors like Nitric oxide, cAMP etc.

 

REFERENCES:

1.      Mc Guigan JE. Peptic ulcer and gastritis. In: Harrison’s Principles of Internal Medicine. McGraw Hill, New York. 1991: 12th ed. pp 537-542.

2.      Goel RK and Bhattacharya SK. Gastro duodenal mucosal defense and mucosal protective agents. Indian Journal of Experimental Biology. 1991; 29: 701-714.

3.      Robert A. Cytoprotection by Prostaglandins. Gastroenterology. 1979; 77: 761-767.

4.      Vergin H, Kori-Linder C. Putative mechanisms of cytoprotective effect of certain antacids and sucralfate. Digestive Diseases and Sciences. 1990; 35: 1320-1327.

5.      Goel RK, Govinda Das D and Sanyal AK. Effect of vegetable banana powder on changes induced by ulcerogenic agents on dissolved muco substances in gastric juice. Indian Journal of Gastroenterology. 1985; 4: 249-251.

6.      Rao Ch V, Sairam K and Goel RK. Experimental evaluation of Bacopa monnieri on rat gastric ulceration and secretion. Indian Journal of Physiology and Pharmacology. 2000; 44: 35-41.

7.      Sairam K, Rao Ch V and Goel RK. Effects of Centella asiatica Linn on physical and chemical factors induced gastric ulceration and secretion. Indian Journal of Experimental Biology. 2001; 39: 137-142.

8.      Mangla JC et al. Effect of duodenal ulcerogens cysteamine, meprizole and MPTP on duodenal myo electric activity in rats. Digestive Diseases and Sciences. 1989; 34: 537-542.

9.      Richards RT, Sharma HM. Free radicals in health and disease. Indian Journal of Clinical Practice. 1991; 2: 15-26.

10.    Khare CP. Azima tetracantha In: Indian Medicinal Plants-An Illustrated Dictionary. Springer, Verlag Berlin Heidelberg. 2007: 1 st ed. pp 76.

11.    Nandgude TD, Bhojwani AP and Krisnhakinage. Analgesic activity of various extracts of leaves of Azima tetracantha Lam. International Journal of Green Pharmacy, 2007; 1(1): 37-38.

12.    Ismail TS et al. Anti-inflammatory activity of Salacia oblonga and Azima tetracantha Lam. J Ethanopharmacol, 1997; 56(2): 145-152.

13.    Ecobichon DJ. The Basis of Toxicology Testing. CRC Press New York.1997: 2nd ed. pp.43-86.

14.    Sanyal AK et al. The effect of cyproheptadine on gastric activity, an experimental study. In: Peptic Ulcer. Munksgaard, Copenhagan. 1971: pp. 312-318.

15.    Shay H, Sun DCH and Gruenstein M. A quantitative method for measuring spontaneous gastric secretion in the rat. Gastroenterology. 1954; 26: 906 - 913.

16.    Takagi K, Kasuya Y and Watanabe K. Studies on the drugs for peptic ulcer. A reliable method for producing stress ulcer in rats. Chem Pharm Bull. 1964; 12: 465-472

17.    Goswami S et al. Evaluation of the ulcer activity of cromokalin, a potassium channel opener in experimentally induced acute and chronic ulcer. Indian Journal of Pharmacology. 1998; 30: 379-389.

18.    Takashi Kobayashi et al. Abnormal functional and morphological regulation of the gastric mucosa in histamine H2 receptor- deficient mice. Journal of Clinical Investigation. 2000; 105: 1741-1749.

19.    Goel RK. Practical Pharmacology. B. S. Shah Prakashan Publication, Ahmadabad, India.2004: 4th ed. pp 146.

20.    Lowry OH et al. Protein measurement with Folin phenol reagent. Journal of Biological chemistry. 1951; 193: 265-275.

21.    Sanyal AK, Mitra PK and Goel RK. A modified method to estimate dissolved muco substances in gastric juice. Indian Journal of Experimental Biology. 1983; 21: 78-80.

22.    Okhawa H, Ohish N and Yagi K. Assay of Lipid peroxides in animal tissues by thio barbituric acid reaction. Anal Biochem. 1979; 95: 351.

23.    Kakkar P, Das B and Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Indian Journal of Biochemistry and Biophysics. 1984; 21: 130-132.

24.    Beers RF, Sizer LW. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by Catalase. Journal of Biological chemistry. 1952; 195: 133-140.

25.    Flemstrong G, Garner A. Gastro duodenal HCO3 transport; characteristics and proposed role in acidity regulation and mucosal protection. American Journal of Physiology. 1982; 242: G153-G193.

26.    Zalewsky CA, Moody FG. Mechanisms of mucus release in exposed canine gastric mucosa. Gastroenterology. 1979; 77: 719-729.

27.    Mukhopadhyay K et al. Effects of banana powder (Musa sapientum Var. paradisiaca) on gastric mucosal shedding. Journal of Ethno pharmacology. 1987; 21: 11-19.

28.    Scheiman JM. NSAIDS, Gastro intestinal injury and Cytoprotection. In: NSAIDS, Eicosanoids and the Gastro enteric tract.  Saunders, Philadelphia.1996: pp 279-298.

29.    Cochran T et al. Dimethyl sulphoxide protection against gastric stress ulceration. Current Surgery. 1983; 40: 435-437.

30.    Pan Ying Ming et al. Antioxidant activities of several Chinese medicine herbs. Food Chemistry. 2004; 88: 347-350.

31.    Fridovich I. Biological effects of Superoxide radical. Archives of Biochemistry and Biophysics. 1986; 247: 1-11.

32.    Das D et al. Hydroxyl radical in the major causative factor in stress induced gastric ulceration. Molecular and Cellular Biochemistry. 1997; 35: 1084-1087.

33.    Miller TA. Mechanism of Stress related mucosal damage. American Journal of Medicine. 1987; 83: 8-14.

34.    Boyd SC et al. Gastric glutathione depletion and acute ulcerogenesis by diethyl malate given subcutaneously to rats. Life Sciences. 1981; 28: 2987-2992.

 

 

 

 

Received on 15.05.2008  Modified on 10.07.2008

Accepted on 10.08.2008  © RJPT All right reserved

Research J. Pharm. and Tech.2 (2): April.-June.2009,;Page 344-348